Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Zhang D et al. Residual detection of buparvaquone, nystatin, and etomidate in animal-derived food products in a single chromatographic run using liquid chromatography-tandem mass spectrometry. 2017 Food Chem pmid:28763970
Lima JF et al. Porosity of temporary denture soft liners containing antifungal agents. 2016 Sep-Oct J Appl Oral Sci pmid:27812615
Chanthick C et al. Caveolae-mediated albumin transcytosis is enhanced in dengue-infected human endothelial cells: A model of vascular leakage in dengue hemorrhagic fever. 2016 Sci Rep pmid:27546060
Ellepola AN et al. Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka. 2016 J Investig Clin Dent pmid:26059506
Streekstra H et al. Fungal strains and the development of tolerance against natamycin. 2016 Int. J. Food Microbiol. pmid:27589020
Sardi JC et al. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp. 2016 Diagn. Microbiol. Infect. Dis. pmid:27638348
Kinoshita H et al. Cryptic antifungal compounds active by synergism with polyene antibiotics. 2016 J. Biosci. Bioeng. pmid:26323525
Hashemy SI et al. Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment. 2016 J. Oral Pathol. Med. pmid:26058710
Marmiroli M et al. A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. 2016 Nanotoxicology pmid:25938282
Oncel MY et al. Author's Reply: role of probiotics in prevention of Candida colonization and invasive candidiasis. 2016 J. Matern. Fetal. Neonatal. Med. pmid:25777578